Company Overview of Frazier Healthcare Ventures
Frazier Healthcare Ventures is a private equity and venture capital firm specializing in growth equity financing; incubation; expansion stage equity; recapitalizations; leveraged recapitalizations; buyouts; spinouts; shareholder liquidity; startups, early stage investments including seed and Series A and B financing rounds; late stage investments including Series C, D, mid venture, middle market, bridge financing, and PIPEs investments; and de novo investments across all stages of a company’s development. It seeks to invest in the biopharmaceutical, biotechnology, medical device, medical products, medical supplies, technology-enabled services, and healthcare service sectors. The firm seeks t...
Two Union Square
601 Union Street
Seattle, WA 98101
Founded in 1991
Key Executives for Frazier Healthcare Ventures
Managing Partner and Founder
Chief Financial Officer and Partner
Compensation as of Fiscal Year 2014.
Frazier Healthcare Ventures Key Developments
Frazier Healthcare Appoints David Socks as Venture Partner
Sep 19 14
Frazier Healthcare announced that David Socks has joined the Frazier Life Sciences team as a Venture Partner to lead the firm's life sciences company creation efforts. Prior to joining Frazier, Mr. Socks co-founded Incline Therapeutics in 2010 and served as its President and Chief Operating Officer. He previously co-founded Cadence Pharmaceuticals in 2004 and served as its Senior Vice President, Corporate Development and Strategy.
Frazier Healthcare Ventures Presents at 12th Annual BIO Investor Forum, Oct-08-2013
Oct 4 13
Frazier Healthcare Ventures Presents at 12th Annual BIO Investor Forum, Oct-08-2013 . Venue: The Palace Hotel, 2 New Montgomery Street, San Francisco, CA 94105, United States.
Frazier Healthcare Announces Executive Appointments
Sep 30 13
Frazier Healthcare announced the closing of its seventh healthcare fund, Frazier Healthcare VII (FH VII). FH VII surpassed its target of $300 million with commitments of $377 million. FH VII investors are comprised of corporate and public pension plans, foundations, endowments, and fund of funds. In conjunction with Frazier Healthcare VII's closing, Brian Morfitt will be promoted to General Partner and Ben Magnano will be promoted to Partner. Brian joined Frazier in 2003 from Summit Partners and Ben joined Frazier in 2006 from Morgan Stanley Venture Partners. Both individuals have contributed significantly to the formation and success of several growth buyout investments. In addition, Dan Estes will be promoted to Vice President. Dan joined Frazier in 2011 from McKinsey & Company and is a member of Frazier's Biopharma team. He has been instrumental with assisting in the review and investment of several portfolio companies such as Semnur Pharmaceutical and Atterocor where he is a board observer.
Similar Private Companies By Industry
Recent Private Companies Transactions